1. Screening of 4-([1,3,4]Oxadiazino[6,5-b]indole-3-yl)aniline Derivatives for Anti-bacterial Activity by in-Silico and in-Vitro Methods.Bhamidipati, M. and K. Swathi. International Journal of Pharmaceutical Sciences and Research, 2019. 10(10): p. 4799-4805. ISI[000493913600003].
[WOS]. HIV_11_2019.
2. Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X. Brai, A., S. Ronzini, V. Riva, L. Botta, C. Zamperini, M. Borgini, C.I. Trivisani, A. Garbelli, C. Pennisi, A. Boccuto, F. Saladini, M. Zazzi, G. Maga, and M. Botta. Molecules, 2019. 24(21): E3988. PMID[31690062].
[PubMed]. HIV_11_2019.
3. Chromenone Derivatives as a Versatile Scaffold with Dual Mode of Inhibition of HIV-1 Reverse Transcriptase-associated Ribonuclease H Function and Integrase Activity. Esposito, F., F.A. Ambrosio, R. Maleddu, G. Costa, R. Rocca, E. Maccioni, R. Catalano, I. Romeo, P. Eleftheriou, D.C. Karia, P. Tsirides, N. Godvani, H. Pandya, A. Corona, S. Alcaro, A. Artese, A. Geronikaki, and E. Tramontano. European Journal of Medicinal Chemistry, 2019. 182: 111617. PMID[31442684].
[PubMed]. HIV_11_2019.
4. Rational Discovery of a Highly Novel and Selective mTor Inhibitor. Jin, S., S. Mikami, N. Scorah, Y. Chen, P. Halkowycz, L.H. Shi, J. Kahana, P. Vincent, R. de Jong, J. Atienza, R. Fabrey, L. Zhang, and M. Lardy. Bioorganic & Medicinal Chemistry Letters, 2019. 29(21): 126659. PMID[31543303].
[PubMed]. HIV_11_2019.
5. Prenylated Coumarins from the Fruits of Manilkara zapota with Potential Anti-inflammatory Effects and anti-HIV Activities. Liu, Y.P., G. Yan, J.M. Guo, Y.Y. Liu, Y.J. Li, Y.Y. Zhao, L. Qiang, and Y.H. Fu. Journal of Agricultural and Food Chemistry, 2019. 67(43): p. 11942-11947. PMID[31622090].
[PubMed]. HIV_11_2019.
6. Absence of Naturally Existing Resistance against the HIV-1 Capsid Inhibitor GS-6207 in HIV-1 Primary Isolates.Margot, N., R. Ram, M. Rhee, and C. Callebaut. HIV Medicine, 2019. 20: p. 171-171. ISI[000494690300367].
[WOS]. HIV_11_2019.
7. Engineering and Characterising a Novel, Highly Potent Bispecific Antibody iMab-CAP256 That Targets HIV-1.Moshoette, T., S.A. Ali, M.A. Papathanasopoulos, and M.A. Killick. Retrovirology, 2019. 16(31): 12pp. PMID[31703699]. PMCID[PMC6842167].
[PubMed]. HIV_11_2019.
8. A Unique Class of Lignin Derivatives Displays Broad anti-HIV Activity by Interacting with the Viral Envelope.Oeyen, M., S. Noppen, E. Vanhulle, S. Claes, B.O. Myrvold, K. Vermeire, and D. Schols. Virus Research, 2019. 274: 197760. PMID[31618614].
[PubMed]. HIV_11_2019.
9. Conformational Restriction Design of Thiophene-biphenyl-DAPY HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Sang, Y., S. Han, C. Pannecouque, E. De Clercq, C. Zhuang, and F. Chen. European Journal of Medicinal Chemistry, 2019. 182: 111603. PMID[31421633].
[PubMed]. HIV_11_2019.
10. One-pot Assembly for Synthesis of 1,4-Dihydropyridine Scaffold and Their Biological Applications. Sharma, M.G., J. Pandya, D.M. Patel, R.M. Vala, V. Ramkumar, R. Subramanian, V.K. Gupta, R.L. Gardas, A. Dhanasekaran, and H.M. Patel. Polycyclic Aromatic Compounds. ISI[000494909100001].
[WOS]. HIV_11_2019.
11. Discovery of Novel Pyrazole Based Dual Inhibitor of HIV and HCV Together with Attenuation of Oxidative Stress.Singh, U.P. and H.R. Bhat. HIV Medicine, 2019. 20: p. 98-98. ISI[000494690300189].
[WOS]. HIV_11_2019.
Patent Citations
This month, no relevant HIV patents were identified.